Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers

Dyslipidemia is a major risk factor for development of atherosclerosis and cardiovascular disease (CVD). Effective lipid-lowering therapies has led to CVD risk reduction. This study evaluated the possible pharmacokinetic interactions between fenofibrate, a peroxisome proliferators-activated receptor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Lee, Hae Won, Kang, Woo Youl, Jung, Wookjae, Gwon, Mi-Ri, Cho, Kyunghee, Yang, Dong Heon, Yoon, Young-Ran, Seong, Sook Jin
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7557955/
https://ncbi.nlm.nih.gov/pubmed/32932576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12090869
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados